ARCHIVES

NTP Panel Completed To Write New Testing, Evolution Guidelines

This article is from The Cancer Letter archive.

Vol. 09 No. 16 | April 22, 1983

Download PDF Visit The Full Archive

Related Articles

FDA Proposes New User Fees for Generics and Biosimilar Products

January 20, 2012

NCI advisors approve recompetition of $62 million phase II contracts program.

November 19, 2004

FDA Asks Advisory Group To Define Role Of Single-Arm Studies In Four Applications

September 4, 2009

Study: Women at Higher Risk Of Estrogen Receptor Positive Breast Cancer After Smoking

February 28, 2014

NCI Sends A Second Letter To Groups About Carboplatin

October 22, 2010

NCI Stands Firm On Assist “Downscaling” Despite 150 Letters From States, Volunteers

January 15, 1993